HLTH Europe is where senior leaders across pharma and life sciences come to meet the broader health ecosystem. Unlike pharma-specific conferences, HLTH Europe is where commercial leaders, R&D executives and scientist gain access to health systems, payers, investors, and policymakers who determine adoption and access.
From live case studies and cross-sector deal conversations, sessions are built around the decisions that matter in drug development, market access, AI-driven R&D, and beyond.
If your looking to find new partners across digital health, engage with ecosystem, or understand the forces shaping the industry, HLTH Europe is the room to be in.
✓
Engage with the broader ecosystem that determines whether your
product reaches patients
HLTH Europe gives you access to health system CMOs and payer executives from across Europe. The people who ultimately control formulary decisions, coverage policies, and clinical adoption.
✓
Find partners across digital health, AI, and clinical trail innovation
With Market Connect meet 1-1 with solution providers across AI drug discovery, real-world data platforms, and clinical trial technology matched to specific R&D, commercial, and BD priorities. Qualify and your pass could be complimentary.
✓
Gain insight on where the industry is heading
The sessions at HLTH Europe address forces reshaping the industry and provides insights on the cross-sector dynamics influencing pharma and life sciences.
✓
Benchmark you strategy against peers
Global pharma executives and AI drug development companies are all at HLTH Europe, alongside the policymakers and 20+ ministries of health writing the rules.
Join us at HLTH Europe and meet the health system, payers, investors, solution providers, and policymakers shaping the industry.
